Avantor, Inc. provides a range of products and services primarily to the biopharma, healthcare, education, and government sectors, as well as advanced technologies and applied materials industries. The company's revenue comes from various segments, including materials and consumables (approximately 50%), equipment and instrumentation (around 30%), and services and specialty procurements (about 20%). Its customers include laboratories, pharmaceutical companies, and research institutions across multiple regions, including the Americas, Europe, and Asia. Factors supporting Avantor's endurance include its established customer relationships and diverse product offerings, while potential limitations may arise from competition and reliance on the cyclical nature of the biopharma industry.
—
Avantor, Inc. provides a range of products and services primarily to the biopharma, healthcare, education, and government sectors, as well as advanced technologies and applied materials industries. The company's revenue comes from various segments, including materials and consumables (approximately 50%), equipment and instrumentation (around 30%), and services and specialty procurements (about 20%). Its customers include laboratories, pharmaceutical companies, and research institutions across multiple regions, including the Americas, Europe, and Asia. Factors supporting Avantor's endurance include its established customer relationships and diverse product offerings, while potential limitations may arise from competition and reliance on the cyclical nature of the biopharma industry.
—
Daily adjusted close
Avantor, Inc. provides a range of products and services primarily to the biopharma, healthcare, education, and government sectors, as well as advanced technologies and applied materials industries. The company's revenue comes from various segments, including materials and consumables (approximately 50%), equipment and instrumentation (around 30%), and services and specialty procurements (about 20%). Its customers include laboratories, pharmaceutical companies, and research institutions across multiple regions, including the Americas, Europe, and Asia. Factors supporting Avantor's endurance include its established customer relationships and diverse product offerings, while potential limitations may arise from competition and reliance on the cyclical nature of the biopharma industry.